Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting

British Journal of Cancer

Volumn 108, Issue 3, 2013, Pages 662-667

  Tiernan, J P ^a   Perry, S L ^a   Verghese, E T ^a   West, N P ^a   Yeluri, S ^a   Jayne, D G ^a   Hughes, T A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; EPITHELIAL GROWTH FACTOR RECEPTOR; FOLATE RECEPTOR 1; GLYCOPROTEIN; GROWTH FACTOR RECEPTOR; TAG 72 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER DIAGNOSIS; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; COLON; COLORECTAL NEOPLASMS; FEMALE; FOLATE RECEPTOR 1; FOLLOW-UP STUDIES; GLYCOPROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECTUM; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84875228644     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.605     Document Type: Article

References (50)

1. Barbet J, Bardies M, Bourgeois M, Chatal J-F, Cherel M, Davodeau F, Faivre-Chauvet A, Gestin J-F, Kraeber-Bodere F (2012) Radiolabeled antibodies for cancer imaging and therapy. Methods Mol Biol 907: 681-697.
2. Bhargava R, Chen B, Klimstra DS, Saltz LB, Hedvat C, Tang LH, Gerald W, Teruya-Feldstein J, Paty PB, Qin J, Shia J (2006) Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa. Cancer 106(8): 1857-1862.
3. Boerman OC, Oyen WJG (2011) Immuno-PET of cancer: a revival of antibody imaging. J Nucl Med 52(8): 1171-1172.
4. Buckley AF, Kakar S (2007) Comparison of the dako EGFR pharmDx kit and zymed EGFR antibody for assessment of EGFR status in colorectal adenocarcinoma. Appl Immunohistochem 15(3): 305-309.
5. Camp RL, Charette LA, Rimm DL (2000) Validation of tissue microarray technology in breast carcinoma. Lab Invest 80(12): 1943-1949.
6. Carrasquillo JA, Pandit-Taskar N, O'Donoghue JA, Humm JL, Zanzonico P, Smith-Jones PM, Divgi CR, Pryma DA, Ruan S, Kemeny NE, Fong Y, Wong D, Jaggi JS, Scheinberg DA, Gonen M, Panageas KS, Ritter G, Jungbluth AA, Old LJ, Larson SM (2011) 124I-huA33 antibody PET of colorectal cancer. J Nucl Med 52(8): 1173-1180.
7. Chen L, Wang Y, Cheng D, Dou S, Liu X, Liu G, Hnatowich DJ, Rusckowski M (2011) Comparing two TAG-72 binding peptides previously identified by phage display as potential imaging agents. Nucl Med Commun 32(10): 920-924.
8. Chen L, Wang Y, Liu X, Dou S, Liu G, Hnatowich DJ, Rusckowski M (2008) A new TAG-72 cancer marker peptide identified by phage display. Cancer Lett 272(1): 122-132.
9. Chen W-T, Khazaie K, Zhang G, Weissleder R, Tung C-H (2005) Detection of dysplastic intestinal adenomas using a fluorescent folate imaging probe. Mol Imaging 4(1): 67-74.
10. Conaghan PJ, Ashraf SQ, Tytherleigh MG, Wilding JL, Tchilian E, Bicknell D, Mortensen NJ, Bodmer WF (2008) Targeted killing of colorectal cancer cell lines by a humanised IgGl monoclonal antibody that binds to membrane-bound carcinoembryonic antigen. Br J Cancer 98(7): 1217-1225.
11. Dawson PM, Blair SD, Begent RHJ, Kelly AMB, Boxer GM, Theodorou NA (1991) The value of radioimmunoguided surgery in 1st and 2nd look laparotomy for colorectal-cancer. Dis Colon Rectum 34(3): 217-222.
12. de Jong GM, Bleichrodt RP, Eek A, WJG Oyen, Boerman OC, Hendriks T (2011) Experimental study of radioimmunotherapy versus chemotherapy for colorectal cancer. Br J Surg 98(3): 436-441.
13. Goetz M, Ziebart A, Foersch S, Vieth M, Waldner MJ, Delaney P, Galle PR, Neurath MF, Kiesslich R (2010) In vivo molecular imaging of colorectal cancer with confocal endomicroscopy by targeting epidermal growth factor receptor. Gastroenterology 138(2): 435-446.
14. Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AMH, Heath RM, Brown JM (2005) Short-term endpoints of conventional versus laparoscopic- assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. The Lancet 365(9472): 1718-1726.
15. Heine M, Nollau P, Masslo C, Nielsen P, Freund B, Bruns OT, Reimer R, Hohenberg H, Peldschus K, Ittrich H, Schumacher U (2011) Investigations on the usefulness of CEACAMs as potential imaging targets for molecular imaging purposes. PLoS ONE 6(12): e28030.
16. Jantscheff P, Terracciano L, Lowy A, Glatz-Krieger K, Grunert F, Micheel B, Brümmer J, Laffer U, Metzger U, Herrmann R, Rochlitz C (2003) Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. J Clin Oncol 21(19): 3638-3646.
17. Jeong M-H, Kim K, Kim E-M, Cheong S-J, Lee C-M, Jeong H-J, Kim DW, Lim ST, Sohn M-H, Chung J (2012) In vivo and in vitro evaluation of Cy5.5 conjugated epidermal growth factor receptor binding peptide. Nucl Med Biol 39(6): 805-812.
18. Johnson VG, Schlom J, Paterson AJ, Bennett J, Magnani JL, Colcher D (1986) Analysis of a human tumor-associated glycoprotein (tag-72) identified by monoclonal-antibody b72.3. Cancer Res 46(2): 850-857.
19. Kaushal S, McElroy MK, Luiken GA, Talamini MA, Moossa AR, Hoffman RM, Bouvet M (2008) Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer. J Gastrointest Surg 12(11): 1938-1950.
20. Kopansky E, Shamay Y, David A (2011) Peptide-directed HPMA copolymerdoxorubicin conjugates as targeted therapeutics for colorectal cancer. J Drug Target 19(10): 933-943.
21. Koppe MJ, Bleichrodt RP, Oyen WJG, Boerman OC (2005) Radioimmunotherapy and colorectal cancer. Br J Surg 92(3): 264-276.
22. Koretz K, Schlag P, Moller P (1990) Expression of epidermal growth-factor receptor in normal colorectal mucosa, adenoma, and carcinoma. Virchows Arc A Pathol Anat Histopathol 416(4): 343-349.
23. Lee JC, Wang ST, Chow NH, Yang HB (2002) Investigation of the prognostic value of coexpressed erbB family members for the survival of colorectal cancer patients after curative surgery. Eur J Cancer 38(8): 1065-1071.
24. Li P, Wang Y, Zeng F, Chen L, Peng Z, Kong LX (2011) Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells. Carbohydr Res 346(6): 801-806.
25. Mahmood U (2010) Optical molecular imaging approaches in colorectal cancer. Gastroenterology 138(2): 419-422.
26. Maraqa L, Cummings M, Peter MB, Shaaban AM, Horgan K, Hanby AM, Speirs V (2008) Carcinoembryonic antigen cell adhesion molecule 6 predicts breast cancer recurrence following adjuvant tamoxifen. Clin Cancer Res 14(2): 405-411.
27. Meller B, Rave-Fraenck M, Breunig C, Schirmer M, Baehre M, Nadrowitz R, Liersch T, Meller J (2011) Novel carcinoembryonic-antigen-(CEA)-specific pretargeting system to assess tumor cell viability after irradiation of colorectal cancer cells. Strahlenther Onkol 187(2): 120-126.
28. Meredith RF, Khazaeli MB, Plott WE, Grizzle WE, Liu T, Schlom J, Russell CD, Wheeler RH, LoBuglio AF (1996) Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer. Clin Cancer Res 2(11): 1811-1818.
29. Meyer T, Gaya AM, Dancey G, Stratford MRL, Othman S, Sharma SK, Wellsted D, Taylor NJ, Stirling JJ, Poupard L, Folkes LK, Chan P-s, Pedley RB, Chester KA, Owen K, Violet JA, Malaroda A, Green AJ, Buscombe J, Padhani AR, Rustin GJ, Begent RH (2009) A phase I trial of radioimmunotherapy with 131I-A5B7 anti-CEA antibody in combination with combretastatin-A4-phosphate in advanced gastrointestinal carcinomas. Clin Cancer Res 15(13): 4484-4492.
30. Muguruma N, Ito S, Bando T, Taoka S, Kusaka Y, Hayashi S, Ichikawa S, Matsunaga Y, Tada Y, Okamura S, Ii K, Imaizumi K, Nakamura K, Takesako K, Shibamura S (1999) Labeled carcinoembryonic antigen antibodies excitable by infrared rays: A novel diagnostic method for micro cancers in the digestive tract. Intern Med 38(7): 537-542.
31. O'Donoghue JA, Smith-Jones PM, Humm JL, Ruan S, Pryma DA, Jungbluth AA, Divgi CR, Carrasquillo JA, Pandit-Taskar N, Fong Y, Strong VE, Kemeny NE, Old LJ, Larson SM (2011) 124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET. J Nucl Med 52(12): 1878-1885.
32. Povoski S, Hatzaras I, Mojzisik C, Arnold M, Hinkle G, Hitchcock C, Young D, Martin E (2012) Antigen-directed cancer surgery for primary colorectal cancer: 15-year survival analysis. Ann Surg Oncol 19(1): 131-138.
33. Qi S, Miao Z, Liu H, Xu Y, Feng Y, Cheng Z (2012) Evaluation of Four Affibody based Near-infrared Fluorescent Probes for Optical Imaging of Epidermal Growth Factor Receptor Positive Tumors. Bioconjug Chem; e-pub ahead of print 4 June 2012.
34. Reddy JA, Low PS (1998) Folate-mediated targeting of therapeutic and imaging agents to cancers. Crit Rev Ther Drug Carrier Syst 15(6): 587-627.
35. Scartozzi M, Bearzi I, Berardi R, Mandolesi A, Fabris G, Cascinu S (2004) Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies. J Clin Oncol 22(23): 4772-4778.
36. Schoffelen R, Sharkey RM, Goldenberg DM, Franssen G, McBride WJ, Rossi EA, Chang C-H, Laverman P, Disselhorst JA, Eek A, van der Graaf WTA, Oyen WJG, Boerman OC (2010) Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a Ga-68-and F-18-labeled hapten peptide in mice with human tumor xenografts. Mol Cancer Ther 9(4): 1019-1027.
37. Schoffelen R, van der Graaf WT, Sharkey RM, Franssen GM, McBride WJ, Chang C-H, Laverman P, Goldenberg DM, Oyen WJ, Boerman OC (2012) Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method. EJNMMI Res 2: 5-5.
38. Sharkey RM, Cardillo TM, Rossi EA, Chang CH, Karacay H, McBride WJ, Hansen HJ, Horak ID, Goldenberg DM (2005) Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody. Nat Med 11(11): 1250-1255.
39. Shia J, Klimstra DS, Nitzkorski JR, Low PS, Gonen M, Landmann R, Weiser MR, Franklin WA, Prendergast FG, Murphy L, Tang LH, Temple L, Guillem JG, Wong WD, Paty PB (2008) Immunohistochemical expression of folate receptor [alpha] in colorectal carcinoma: patterns and biological significance. Hum Pathol 39(4): 498-505.
40. Smith AE, Pinkney M, Piggott NH, Calvert H, Milton ID, Lunec J (2007) Novel monoclonal antibody for detection of folate receptor alpha in paraffin-embedded tissues. Hybridoma 26(5): 281-288.
41. Spano J-P, Lagorce C, Atlan D, Milano G, Domont J, Benamouzig R, Attar A, Benichou J, Martin A, Morere J-F, Raphael M, Penault-Llorca F, Breau J-L, Fagard R, Khayat D, Wind P (2005) Impact of EGFR expression on colorectal cancer patient prognosis and survival. Ann Oncol 16(1): 102-108.
42. Sun D, Bloomston M, Hinkle G, Al-Saif OH, Hall NC, Povoski SP, Arnold MW, Martin EW (2007) Radioimmunoguided surgery (RIGS), PET/CT image-guided surgery, and fluorescence image-guided surgery: Past, present, and future. J Surg Oncol 96(4): 297-308.
43. Tang Y, Yang S, Gariépy J, Scollard DA, Reilly RM (2007) Construction and evaluation of the tumor imaging properties of 123I-labeled recombinant and enzymatically generated fab fragments of the TAG-72 monoclonal antibody CC49. Bioconjug Chem 18(3): 677-684.
44. Tiernan JP, Ansari I, Hirst NA, Millner PA, Hughes TA, Jayne DG (2012) Intra-operative tumour detection and staging in colorectal cancer surgery. Colorectal Dis 14(9): e510-20.
45. Torhorst J, Bucher C, Kononen J, Haas P, Zuber M, Kochli OR, Mross F, Dieterich H, Moch H, Mihatsch M, Kallioniemi OP, Sauter G (2001) Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 159(6): 2249-2256.
46. Vigor KL, Kyrtatos PG, Minogue S, Al-Jamal KT, Kogelberg H, Tolner B, Kostarelos K, Begent RH, Pankhurst QA, Lythgoe MF, Chester KA (2010) Nanoparticles functionalised with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells. Biomaterials 31(6): 1307-1315.
47. Yang S-J, Lin F-H, Tsai K-C, Wei M-F, Tsai H-M, Wong J-M, Shieh M-J (2010) Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells. Bioconjug Chem 21(4): 679-689.
48. Yazaki PJ, Kassa T, Cheung C-w, Crow DM, Sherman MA, Bading JR, Anderson A-LJ, Colcher D, Raubitschek A (2008) Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion protein. Nucl Med Biol 35(2): 151-158.
49. Zhang L, Zhu W, Yang C, Guo H, Yu A, Ji J, Gao Y, Sun M, Zhai G (2012) A novel folate-modified self-microemulsifying drug delivery system of curcumin for colon targeting. Int J Nanomedicine 7: 151-162.
50. Zou P, Xu S, Povoski SP, Wang A, Johnson MA, Martin EW, Subramaniam V, Xu R, Sun D (2009) Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice. Mol Pharm 6(2): 428-440.